• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store

Early in Pandemic, HIV Testing Dropped Sharply, but Quickly Rebounded

by Glenn S. Demby | Jan 26, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Testing Trends-dtet

A recent CDC report concludes that disruptions to HIV testing due to the COVID-19 pandemic compromised America’s ability to prevent the disease.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
New Insight into Deaths of US Cancer Patients Due to COVID-19

New Insight into Deaths of US Cancer Patients Due to COVID-19

by Rachel Muenz | Oct 4, 2022 | News, Open Content

Recent study provides new details on how COVID-19 impacted cancer deaths in the US early in the pandemic and which groups were most affected.

Inadequate Reimbursement Threatens Monkeypox Lab Testing Response

Inadequate Reimbursement Threatens Monkeypox Lab Testing Response

by Glenn S. Demby | Sep 30, 2022 | Essential, Laboratory Industry Report, Reimbursement-lir

ACLA and public health experts warn that current reimbursement rates will hamper US efforts to contain monkeypox spread.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
FDA to Issue Emergency Use Authorization for Monkeypox Tests

FDA to Issue Emergency Use Authorization for Monkeypox Tests

by Glenn S. Demby | Sep 13, 2022 | Essential, FDA-nir, National Lab Reporter

In a move to expand access to lab testing for monkeypox, HHS has authorized the FDA to issue EUAs for in vitro diagnostic tests for the virus.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Quest and Color Health Join CDC to Promote Equitable COVID-19 Testing

Quest and Color Health Join CDC to Promote Equitable COVID-19 Testing

by Glenn S. Demby | Jul 29, 2022 | Deals-lir, Essential, Laboratory Industry Report

In July, ICATT took a major step toward equitable access to testing by enlisting two of the country’s leading COVID-19 PCR test providers.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com